Top Markets
#1 Official Trump Official Trump +45.74%
#2 Movement Movement +26.70%
#3 Zama Zama +26.06%
#4 Mubarak Mubarak +25.19%
#5 Melania Meme Melania Meme +22.92%
#6 Pearl Pearl +21.29%
#7 EXOD EXOD +18.93%
#8 Wrapped POL Wrapped POL +18.07%
#9 POL (ex-MATIC) POL (ex-MATIC) +16.59%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +15.99%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Rank in Stocks #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Share Price
$3.78
Last synced: 2026-08-21
Market Cap
$71.20M
Change (1 day)
2.24%
Change (1 year)
-43.37%
Country
FR
Trade MaaT Pharma S.A. (MAAT)

Category

Healthcare
Number of shares outstanding for MaaT Pharma S.A. (MAAT)
Number of shares outstanding as of August 2026: 0
According to MaaT Pharma S.A. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for MaaT Pharma S.A. (MAAT) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH